Cargando…
Hematopoietic Stem Cell Transplant for Hematological Malignancies: Experience from a Tertiary Care Center in Northern India and Review of Indian Data
Hematopoietic stem cell transplantation (HSCT) is the preferred treatment for high-risk and relapsed/refractory hematological malignancies. Moreover, with the improved supportive care and increasing acceptance of haploidentical transplantations as an alternative treatment modality, more patients are...
Autores principales: | Sharma, Sanjeev Kumar, Choudhary, Dharma, Doval, Divya, Khandelwal, Vipin, Setia, Rasika, Dadu, Tina, Handoo, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273315/ https://www.ncbi.nlm.nih.gov/pubmed/35833052 http://dx.doi.org/10.1055/s-0041-1731599 |
Ejemplares similares
-
Real-world outcomes of stem cell transplantation for severe aplastic anemia: A single-center experience in Northern India
por: Choudhury, Dharma, et al.
Publicado: (2020) -
Allogeneic stem cell transplant for myelofibrosis- A retrospective single-center study
por: Choudhary, Dharma, et al.
Publicado: (2023) -
Cost of Hematopoietic Stem Cell Transplantation in India
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2014) -
Outcome of 51 autologous peripheral blood stem cell transplants after uncontrolled-rate freezing (“dump freezing”) using −80°C mechanical freezer
por: Setia, Rasika Dhawan, et al.
Publicado: (2018) -
Flow Cytometric DNA Ploidy Analysis in Haemato-Lymphoid Neoplasms: An Analysis of 132 Cases
por: Gupta, Nishit, et al.
Publicado: (2022)